Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Citadel Advisors LLC
Symbol
SPRB
Shares outstanding
1,097,588 shares
Disclosed Ownership
109,649 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
16 Oct 2025, 17:10:09 UTC
Date of event
09 Oct 2025
Next filing
17 Feb 2026

Sponsored

Quoteable Key Fact

"CITADEL ADVISORS LLC disclosed 10% ownership in Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") (SPRB) on 09 Oct 2025."

Quick Takeaways

  • CITADEL ADVISORS LLC filed SCHEDULE 13G for Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") (SPRB).
  • Disclosed ownership: 10%.
  • Date of event: 09 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 16 Oct 2025, 17:10.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 10% 109,649 0 109,649 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 10% 109,649 0 109,649 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 10% 109,649 0 109,649 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 0 0 0 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 0% 0 0 0 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 0% 0 0 0 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 10% 109,649 0 109,649 /s/ Seth Levy Seth Levy, attorney-in-fact*